BioNTech SE (BNTX) Net Income towards Common Stockholders (2018 - 2026)
BioNTech SE's Net Income towards Common Stockholders was $212.25 million in Q3 2026, compared with -$33.55 million a year earlier.
Powered by 
Analysis
BioNTech SE (BNTX) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioNTech SE's Net Income towards Common Stockholders was -$1.72 billion through Sep 30, 2026; for FY2025, it was -$1.28 billion.
- In earlier years, Net Income towards Common Stockholders was -$720.08 million in FY2024, $1.01 billion in FY2023 (-89.9%), $9.94 billion in FY2022 (-18.4%) and $12.18 billion in FY2021.
- The Q3 2026 figure marks the highest quarterly Net Income towards Common Stockholders since Q4 2024.
- The best year-over-year quarter for Net Income towards Common Stockholders over five years was Q4 2021 (growth of 728.0%); the worst was Q3 2023 (a decline of 90.3%).
- Per Business Quant data, BNTX's Net Income towards Common Stockholders in the three quarters before Q3 2026 was -$954.07 million (Q2 2026), -$622.72 million (Q1 2026) and -$355.03 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.24 Bn |
| 10 | BioNTech SE | 22.05 Bn | -37.46 Bn | 1.36 Bn | 212.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 212.25 Mn |
| Jun 30, 2026 | -954.07 Mn |
| Mar 31, 2026 | -622.72 Mn |
| Dec 31, 2025 | -355.03 Mn |
| Sep 30, 2025 | -33.55 Mn |
| Jun 30, 2025 | -437.62 Mn |
| Mar 31, 2025 | -453.15 Mn |
| Dec 31, 2024 | 277.30 Mn |
| Sep 30, 2024 | 217.56 Mn |
| Jun 30, 2024 | -869.91 Mn |
| Mar 31, 2024 | -342.31 Mn |
| Dec 31, 2023 | 492.67 Mn |
| Sep 30, 2023 | 174.83 Mn |
| Jun 30, 2023 | -207.33 Mn |
| Mar 31, 2023 | 539.03 Mn |
| Dec 31, 2022 | 2.32 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 4.15 Bn |
| Dec 31, 2021 | 3.62 Bn |
API Access
BioNTech SE Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();